![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 45, 46706-46714, November 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

¶

||

From the
Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Ancona 60131, Italy, the
Laboratory of Cytology, Italian National Research Centers on Aging, Ancona 60124, Italy, and the ||Neural Development Group, Mouse Cancer Genetics Program, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21701
Malignant mesothelioma (MM) is strongly resistant to conventional chemotherapy by unclear mechanisms. We and others have previously reported that cytokine- and growth factor-mediated signal transduction is involved in the growth and progression of MM. Here, we identified a pathway that involves stem cell factor (SCF)/c-Kit/Slug in mediating multidrug resistance of MM cells. When we compared gene expression profiles between five MM cells and their multidrug-resistant (MM DX) sublines, we found that MM DX cells expressed both SCF and c-Kit and had higher mRNA levels of Slug. Knockdown of c-Kit or Slug expression with their respective small interfering RNA sensitized MM DX cells to the induction of apoptosis by different chemotherapeutic agents, including doxorubicin, paclitaxel, and vincristine. Transfection of c-Kit in parental MM cells in the presence of SCF up-regulated Slug and increased resistance to the chemotherapeutic agents. Moreover, MM cells expressing Slug showed a similar increased resistance to the chemotherapeutic agents. These results indicate that induction of Slug by autocrine production of SCF and c-Kit activation plays a key role in conferring a broad spectrum chemoresistance on MM cells and reveal a novel signal transduction pathway for pharmacological or genetic intervention of MM patients.
Received for publication, June 16, 2004 , and in revised form, August 23, 2004.
* This work was supported by grants from the Italian Ministry of Research and from Associazione Italiana per la Ricerca contro il Cancro (to A. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Supported by a fellowship from Fondazione Italiana per la Ricerca contro il Cancro. To whom correspondence should be addressed: Dept. of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Via Ranieri, Ancona 60131, Italy. Tel.: 39-0712204623; Fax: 39-0712204618; E-mail: catgfp{at}yahoo.it.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Lazzarini, S. Moretti, S. Orecchia, P.-G. Betta, A. Procopio, and A. Catalano Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma Clin. Cancer Res., August 15, 2008; 14(16): 5099 - 5107. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Riganti, S. Doublier, E. Aldieri, S. Orecchia, P. G. Betta, E. Gazzano, D. Ghigo, and A. Bosia Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1{alpha} Eur. Respir. J., August 1, 2008; 32(2): 443 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vitali, C. Mancini, V. Cesi, B. Tanno, M. Mancuso, G. Bossi, Y. Zhang, R. V. Martinez, B. Calabretta, C. Dominici, et al. Slug (SNAI2) Down-Regulation by RNA Interference Facilitates Apoptosis and Inhibits Invasive Growth in Neuroblastoma Preclinical Models Clin. Cancer Res., July 15, 2008; 14(14): 4622 - 4630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Moretti, A. Procopio, R. Lazzarini, M. R. Rippo, R. Testa, M. Marra, L. Tamagnone, and A. Catalano Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts Blood, February 15, 2008; 111(4): 2290 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Voisset, S. Lopez, P. Dubreuil, and P. De Sepulveda The tyrosine kinase FES is an essential effector of KITD816V proliferation signal Blood, October 1, 2007; 110(7): 2593 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bertino, C. Porta, D. Barbone, S. Germano, S. Busacca, S. Pinato, G. Tassi, R. Favoni, G. Gaudino, and L. Mutti Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed Thorax, August 1, 2007; 62(8): 690 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Tsao, D. He, B. Saigal, S. Liu, J. J. Lee, S. Bakkannagari, N. G. Ordonez, W. K. Hong, I. Wistuba, and F. M. Johnson Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion Mol. Cancer Ther., July 1, 2007; 6(7): 1962 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Turner, S. Broad, F. L. Khanim, A. Jeanes, S. Talma, S. Hughes, C. Tselepis, and N. A. Hotchin Slug Regulates Integrin Expression and Cell Proliferation in Human Epidermal Keratinocytes J. Biol. Chem., July 28, 2006; 281(30): 21321 - 21331. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catalano, P. Caprari, S. Moretti, M. Faronato, L. Tamagnone, and A. Procopio Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function Blood, April 15, 2006; 107(8): 3321 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang and S. K. Roy Expression of Growth Differentiation Factor 9 in the Oocytes Is Essential for the Development of Primordial Follicles in the Hamster Ovary Endocrinology, April 1, 2006; 147(4): 1725 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Shih, M.-F. Tsai, T.-H. Chang, Y.-L. Chang, A. Yuan, C.-J. Yu, S.-B. Lin, G.-Y. Liou, M.-L. Lee, J. J.W. Chen, et al. Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma Clin. Cancer Res., November 15, 2005; 11(22): 8070 - 8078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barrallo-Gimeno and M. A. Nieto The Snail genes as inducers of cell movement and survival: implications in development and cancer Development, July 15, 2005; 132(14): 3151 - 3161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |